A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Azacitidine
Teduglutide
The serum concentration of Ketazolam can be increased when it is combined with Teduglutide.
Azacitidine
Sodium oxybate
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Azacitidine
Thalidomide
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Azacitidine
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.
Azacitidine
Suvorexant
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Azacitidine
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketazolam.
Azacitidine
Rotigotine
Ketazolam may increase the sedative activities of Rotigotine.
Azacitidine
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.
Azacitidine
Paraldehyde
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Azacitidine
Orphenadrine
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Azacitidine
Methotrimeprazine
Methotrimeprazine may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.
Azacitidine
Hydrocodone
Ketazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Etretinate
Obeticholic acid
The risk or severity of adverse effects can be increased when Ursodeoxycholic acid is combined with Obeticholic acid.
Etretinate
Propacetamol
Ursodeoxycholic acid may increase the hepatotoxic activities of Propacetamol.
Etretinate
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Ursodeoxycholic acid.
Etretinate
Trabectedin
The metabolism of Trabectedin can be decreased when combined with Ursodeoxycholic acid.
Etretinate
Felbamate
The metabolism of Felbamate can be increased when combined with Ursodeoxycholic acid.
Etretinate
Selumetinib
The metabolism of Selumetinib can be decreased when combined with Ursodeoxycholic acid.
Etretinate
Fingolimod
The metabolism of Fingolimod can be decreased when combined with Ursodeoxycholic acid.
Etretinate
Cenobamate
The metabolism of Cenobamate can be decreased when combined with Ursodeoxycholic acid.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3